Literature DB >> 24857227

[Chinese guidelines for diagnosis and treatment of acute promyelocytic leukemia (2014)].

Ma Jun.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24857227     DOI： 10.3760/cma.j.issn.0253-2727.2014.05.024

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN： 0253-2727


× No keyword cloud information.
  6 in total

1.  Successful treatment of acute promyelocytic leukemia in a 92-year-old man using all-trans retinoic acid combined with oral arsenic: A case report.

Authors:  Xiaowei Shi; Shuangyue Li; Shanhao Tang; Ying Lu
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

2.  [The analysis of prognosis-associated factors in adults with acute promyelocytic leukemia].

Authors:  R J Ma; Z M Zhu; X L Yuan; L Jiang; S W Yang; J Yang; J M Guo; J Shi; P C Lei; L Zhang; B J Shang; K Sun; Y P Zhai; W Li; Y Zhang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-07-14

3.  External quality assessment for PML-RARα detection in acute promyelocytic leukemia: Findings and summary.

Authors:  Qisheng Wu; Rui Zhang; Yu Fu; Jiawei Zhang; Kun Chen; Jinming Li
Journal:  J Clin Lab Anal       Date:  2019-05-26       Impact factor: 2.352

4.  Circulating Monocytic Myeloid-Derived Suppressor Cells Are Elevated and Associated with Poor Prognosis in Acute Myeloid Leukemia.

Authors:  Huiping Wang; Qianshan Tao; Zhitao Wang; Qing Zhang; Hao Xiao; Mei Zhou; Yi Dong; Zhimin Zhai
Journal:  J Immunol Res       Date:  2020-12-21       Impact factor: 4.818

Review 5.  Influencing Factors and Coping Strategies of Hospitalization in Children with Leukemia Complicated with Pneumonia.

Authors:  Rongmei Xiang; Jiang Yi
Journal:  Comput Math Methods Med       Date:  2022-07-15       Impact factor: 2.809

6.  Significance of ETV6 rearrangement in acute promyelocytic leukemia with t(15;17)/promyelocytic leukemia/retinoic acid receptor alpha.

Authors:  N A Gao; Wen-Zheng Yu; Xue-Xia Wang; Jian-Rong Sun; Ning Yu; Zeng-Yan Liu; Xiao-Dan Liu; Ren-Tong Liu; Rui Feng; Bu-Tong Ding; Tan Sang; Nong-Jian Guo
Journal:  Oncol Lett       Date:  2016-05-06       Impact factor: 2.967
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.